Concise Health Risk Tracking Scale: A Brief Self-Report and Clinician Rating of Suicidal Risk
The DOI matches its Crossref record; 22 of the 22 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: Monitoring suicidality and risk following initiation of antidepressant treatment is an essential component of clinical care, but few brief, reliable ratings of suicidal ideation and behavior in adults are available. This report evaluates the psychometric properties of a brief self- and clinician-rated measure of factors related to the risk of suicide attempt or completion. METHOD: Adult outpatients with nonpsychotic major depressive disorder (MDD) (n = 240) were enrolled from July 2007 through February 2008 and treated in an 8-week, open-label trial with the clinician's choice of a selective serotonin reuptake inhibitor at 6 primary care and 9 psychiatric clinical care settings in the National Institute of Mental Health-funded Depression Trials Network. Diagnosis of MDD was determined by the Psychiatric Diagnostic Screening Questionnaire and an MDD checklist based on DSM-IV-TR criteria. Suicidal ideation and behavior are 1 of 9 symptoms of MDD (depressed mood, loss of interest, appetite or weight change, sleep disturbance, reduced concentration or indecisiveness, fatigue or decreased energy, psychomotor agitation or retardation, feelings of worthlessness, or excessive guilt). The newly developed Concise Health Risk Tracking (CHRT) scale was administered both as the CHRT Self-Report (CHRT-SR) and Clinician Rating (CHRT-C) scales. Psychometric evaluations were conducted on both scales. RESULTS: The internal consistency (Cronbach α) was .77 for the 7-item CHRT-C and .78 for the 7-item CHRT-SR with a consistent factor structure, and 3 independent factors (current suicidal thoughts and plans, perceived lack of social support, and hopelessness) for both versions. CONCLUSIONS: The 7-item CHRT-C and the 7-item CHRT-SR have excellent psychometric properties and can be used to monitor suicidal risk in clinical practice and research settings. Whether either scale will predict suicide attempts or completions in actual practice would require a very large prospective study sample. TRIAL REGISTRATION: Clinicaltrials.gov Identifier: NCT00532103.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
An inventory for measuring clinical anxiety: Psychometric properties.
Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.56.6.893 · Cited by 14,407
Development of a Rating Scale for Primary Depressive Illness
HAMILTON, M. (1967) · British Journal of Social and Clinical Psychology · doi:10.1111/j.2044-8260.1967.tb00530.x · Cited by 8,410
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879
Self-citationRush, A. J., Trivedi, M. H., Ibrahim, H. M., Carmody, T. J., Arnow, B., Klein, D. N., Markowitz, J. C., Ninan, P. T., Kornstein, S., Manber, R., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(02)01866-8 · Cited by 3,829
Self-citationSangha, O., Stucki, G., Liang, M. H., Fossel, A. H., & Katz, J. N. (2003) · Arthritis Care & Research · doi:10.1002/art.10993 · Cited by 1,806
Posner, K., Oquendo, M. A., Gould, M., Stanley, B., & Davies, M. (2007) · American Journal of Psychiatry · doi:10.1176/ajp.2007.164.7.1035 · Cited by 1,025
TRIVEDI, M. H., RUSH, A. J., IBRAHIM, H. M., CARMODY, T. J., BIGGS, M. M., SUPPES, T., CRISMON, M. L., SHORES-WILSON, K., TOPRAC, M. G., DENNEHY, E. B., et al. (2004) · Psychological Medicine · doi:10.1017/s0033291703001107 · Cited by 968
Self-citationRush, A. J., Carmody, T., & Reimitz, P. (2000) · International Journal of Methods in Psychiatric Research · doi:10.1002/mpr.79 · Cited by 427
Self-citationZimmerman, M., & Mattia, J. I. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.8.787 · Cited by 375
Cited by
Maj, M., Stein, D. J., Parker, G., Zimmerman, M., Fava, G. A., De Hert, M., Demyttenaere, K., McIntyre, R. S., Widiger, T., & Wittchen, H. (2020) · World Psychiatry · doi:10.1002/wps.20771 · Cited by 435
Ketamine for rapid reduction of suicidal ideation: a randomized controlled trial
Murrough, J. W., Soleimani, L., DeWilde, K. E., Collins, K. A., Lapidus, K. A., Iacoviello, B. M., Lener, M., Kautz, M., Kim, J., Stern, J. B., et al. (2015) · Psychological Medicine · doi:10.1017/s0033291715001506 · Cited by 297
“Ketamine was superior to midazolam in reducing levels of irritability (p = 0.025) and panic (p = 0.032) as measured by the CAST 24 h post-treatment.”
MethodInfluentialBatterham, P. J., Ftanou, M., Pirkis, J., Brewer, J. L., Mackinnon, A. J., Beautrais, A., Fairweather-Schmidt, A. K., & Christensen, H. (2015) · Psychological Assessment · doi:10.1037/pas0000053 · Cited by 264
“…Scale of Suicide Ideation and the BSSI (Beck et al., 1988) Three factors: Desire for Death, Preparation for death and Active Suicidal Desire (Steer et al., 1993) Detected High agreement between the self-rated and clinician rated versions ( ranging from.63 to.81) (Trivedi et al., 2011).”
Christopher, M. S., Hunsinger, M., Goerling, L. R. J., Bowen, S., Rogers, B. S., Gross, C. R., Dapolonia, E., & Pruessner, J. C. (2018) · Psychiatry Research · doi:10.1016/j.psychres.2018.03.059 · Cited by 173
“PROMIS measures have variable ranges (sleep disturbance [32 – 76], alcohol use [ 39 – 77 ], anxiety [ Suicidal ideation was assessed using the 7-item Concise Health Risk Tracking scale (CHRT; Trivedi et al., 2011).”
InfluentialCelano, C. M., Beale, E. E., Mastromauro, C. A., Stewart, J. G., Millstein, R. A., Auerbach, R. P., Bedoya, C. A., & Huffman, J. C. (2017) · Psychological Medicine · doi:10.1017/s0033291716002798 · Cited by 89
Friedman, E. S., Davis, L. L., Zisook, S., Wisniewski, S. R., Trivedi, M. H., Fava, M., & Rush, A. J. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2011.07.010 · Cited by 81
Self-citationBerrouiguet, S., Barrigón, M. L., Castroman, J. L., Courtet, P., Artés-Rodríguez, A., & Baca-García, E. (2019) · BMC Psychiatry · doi:10.1186/s12888-019-2260-y · Cited by 84
Psychometric properties of the concise health risk tracking (CHRT) in adolescents with suicidality
Mayes, T. L., Kennard, B. D., Killian, M., Carmody, T., Grannemann, B. D., Rush, A. J., Jha, M. K., Hughes, J., Emslie, G. J., & Trivedi, M. H. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.03.007 · Cited by 55
Self-citationTrivedi, M., Jha, M., Kahalnik, F., Pipes, R., Levinson, S., Lawson, T., Rush, A., Trombello, J., Grannemann, B., Tovian, C., et al. (2019) · Pharmaceuticals · doi:10.3390/ph12020071 · Cited by 49
“Clinicians have the option to administer additional validated instruments for detailed suicide risk assessments, including the Concise Health Risk Tracking (CHRT) scale [61], which has been validated in diverse groups of patients with psychiatric disorders [62–64].”
Self-citationDichtel, L. E., Nyer, M., Dording, C., Fisher, L. B., Cusin, C., Shapero, B. G., Pedrelli, P., Kimball, A. S., Rao, E. M., Mischoulon, D., et al. (2020) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.19m12887 · Cited by 40
Self-citationEaddy, M., Zullo, L., Horton, S. E., Hughes, J. L., Kennard, B., Diederich, A., Emslie, G. J., Schuster, L., & Stewart, S. M. (2019) · Suicide and Life-Threatening Behavior · doi:10.1111/sltb.12472 · Cited by 32
Pharmacologic approaches to suicide prevention
Zisook, S., Domingues, I., & Compton, J. (2023) · Focus · doi:10.1176/appi.focus.20220076 · Cited by 30
Self-citationMartin-Cook, K., Palmer, L., Thornton, L., Rush, A. J., Tamminga, C. A., & Ibrahim, H. M. (2021) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s308615 · Cited by 25
Self-citationOlgiati, P., & Serretti, A. (2022) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000416 · Cited by 20
Multidimensional variability in ecological assessments predicts two clusters of suicidal patients.
Bonilla-Escribano, P., Ramírez, D., Baca-García, E., Courtet, P., Artés-Rodríguez, A., & López-Castromán, J. (2023) · Scientific Reports · doi:10.1038/s41598-023-30085-1 · Cited by 17
Trombello, J. M., Pizzagalli, D. A., Weissman, M. M., Grannemann, B. D., Cooper, C. M., Greer, T. L., Malchow, A. L., Jha, M. K., Carmody, T. J., Kurian, B. T., et al. (2018) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2018.04.003 · Cited by 16
Self-citationMeasurement choices for youth suicidality
Busby, D. R., Hughes, J. L., Walters, M., Ihediwa, A., Adeniran, M., Goodman, L., & Mayes, T. L. (2025) · Child Psychiatry & Human Development · doi:10.1007/s10578-023-01627-5 · Cited by 8
“Several versions of the CHRT-SR have been developed to include additional risk factors, such as impulsivity and irritability, which may be important considerations with certain populations [62, 95].”
InfluentialWalker, R., Northrup, T. F., Tillitski, J., Bernstein, I., Greer, T. L., & Trivedi, M. H. (2019) · Substance Use & Misuse · doi:10.1080/10826084.2018.1467453 · Cited by 5
“The SSSA total score was significantly and positively correlated with the CHRT-SR (r¼ 0.35 to 0.64) and P-FIBS (r¼ 0.17 to 0.27) in the entire sample, the Cocaine group, and Cocaine/Other Stimulant group but was not significant in the Other Stimulant Use group.”
BackgroundInfluentialSelf-citation
Metadata
- Authors
- Trivedi, M. H., Wisniewski, S. R., Morris, D. W., Fava, M., Gollan, J. K., Warden, D., Nierenberg, A. A., Gaynes, B. N., Husain, M. M., Luther, J. F., Zisook, S., & Rush, A. J.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2011-06-15
- Volume
- 72
- Issue
- 06
- Pages
- 757-764
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2024266534
- Cited by
- 164
- References
- 22
- FWCI
- 6.94
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.